You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Moodys
Harvard Business School
Johnson and Johnson
Medtronic

Last Updated: October 2, 2023

Drug Price Trends for TACROLIMUS


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for TACROLIMUS

Average Pharmacy Cost for TACROLIMUS

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
TACROLIMUS 0.03% OINTMENT 00168-0417-60 1.10802 GM 2023-09-20
TACROLIMUS 0.03% OINTMENT 00168-0417-30 1.62654 GM 2023-09-20
TACROLIMUS 0.03% OINTMENT 00093-3428-30 1.62654 GM 2023-09-20
TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE) 70748-0221-01 1.12919 EACH 2023-09-20
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for TACROLIMUS

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
PROTOPIC 0.03% OINT,TOP LEO Pharma, Inc. 50222-0203-30 30GM 217.66 7.25533 GM 2023-05-15 - 2028-05-14 Big4
PROTOPIC 0.03% OINT,TOP LEO Pharma, Inc. 50222-0203-30 30GM 285.47 9.51567 GM 2023-05-15 - 2028-05-14 FSS
PROTOPIC 0.1% OINT, TOP LEO Pharma, Inc. 50222-0211-10 100GM 723.21 7.23210 GM 2023-05-15 - 2028-05-14 Big4
PROTOPIC 0.1% OINT, TOP LEO Pharma, Inc. 50222-0211-10 100GM 951.59 9.51590 GM 2023-05-15 - 2028-05-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Colorcon
McKesson
Harvard Business School
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.